Nordic Nanovector Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 24

Employees

  • Latest Deal Type
  • M&A

Nordic Nanovector General Information

Description

Thor Medical ASA is a Norway-based biopharmaceutical company. The company is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium. The Company is utilizing alpha-emitters in radiotherapy and cancer treatments using Pb-212, which can be produced from naturally occurring isotope Thorium-232 and Lead-212. It uses a proprietary production process that does not involve irradiation or nuclear reactors to produce alpha-emitting materials. These materials are used by radiopharmaceutical companies in the development of cancer therapies.

Contact Information

Website
www.nordicnanovector.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Kjelsasveien 168 B
  • 0884 Oslo
  • Norway
+47 22
Primary Industry
Drug Discovery
Acquirer
Thor Medical
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Kjelsasveien 168 B
  • 0884 Oslo
  • Norway
+47 22

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nordic Nanovector Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Merger/Acquisition 03-Jul-2023 Completed Generating Revenue
13. PIPE 14-Mar-2022 Completed Generating Revenue
12. PIPE 24-Jan-2022 Completed Generating Revenue
11. PIPE 23-Feb-2021 Completed Generating Revenue
10. PIPE 23-Sep-2020 Completed Generating Revenue
9. PIPE 18-Oct-2019 Completed Generating Revenue
8. PIPE 25-Jan-2019 Completed Generating Revenue
7. Merger/Acquisition 20-Feb-2017 Cancelled Generating Revenue
6. PIPE 07-Dec-2016 $58.8M $187M Completed Generating Revenue
5. IPO 23-Mar-2015 $72.6M $128M Completed Generating Revenue
To view Nordic Nanovector’s complete valuation and funding history, request access »

Nordic Nanovector Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Thor Medical ASA is a Norway-based biopharmaceutical company. The company is a producer and supplier of alpha-particle e
Drug Discovery
Oslo, Norway
24 As of 2026

Cambridge, MA
 

Leeds, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nordic Nanovector Competitors (26)

One of Nordic Nanovector’s 26 competitors is Agios Pharmaceuticals, a Formerly VC-backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Agios Pharmaceuticals Formerly VC-backed Cambridge, MA
4D pharma Corporation Leeds, United Kingdom
Sutro Biopharma Formerly VC-backed South San Francisco, CA
Inhibrx Formerly VC-backed La Jolla, CA
BioSynthema Corporate Backed or Acquired Saint Louis, MO
You’re viewing 5 of 26 competitors. Get the full list »

Nordic Nanovector Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nordic Nanovector Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Birk Venture Venture Capital Minority
HealthCap Venture Capital Minority
Radforsk Investeringsstiftelse Venture Capital Minority
The Research Council of Norway Government Minority
To view Nordic Nanovector’s complete investors history, request access »

Ready to get started?

Request a free trial

Nordic Nanovector ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Commercial Services

Industry

Rank

Percentile

Business Support Services

Subindustry

Rank

Percentile

To view Nordic Nanovector’s complete esg history, request access »

Nordic Nanovector FAQs

  • When was Nordic Nanovector founded?

    Nordic Nanovector was founded in 2009.

  • Where is Nordic Nanovector headquartered?

    Nordic Nanovector is headquartered in Oslo, Norway.

  • What is the size of Nordic Nanovector?

    Nordic Nanovector has 24 total employees.

  • What industry is Nordic Nanovector in?

    Nordic Nanovector’s primary industry is Drug Discovery.

  • Is Nordic Nanovector a private or public company?

    Nordic Nanovector is a Private company.

  • What is Nordic Nanovector’s current revenue?

    The current revenue for Nordic Nanovector is .

  • How much funding has Nordic Nanovector raised over time?

    Nordic Nanovector has raised $336M.

  • Who are Nordic Nanovector’s investors?

    Birk Venture, HealthCap, Radforsk Investeringsstiftelse, and The Research Council of Norway have invested in Nordic Nanovector.

  • Who are Nordic Nanovector’s competitors?

    Agios Pharmaceuticals, 4D pharma, Sutro Biopharma, Inhibrx, and BioSynthema are some of the 26 competitors of Nordic Nanovector.

  • When was Nordic Nanovector acquired?

    Nordic Nanovector was acquired on 03-Jul-2023.

  • Who acquired Nordic Nanovector?

    Nordic Nanovector was acquired by Thor Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process